Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms

MLA

Yu-Wei Leu, et al. “Aberrant Let7a/HMGA2 Signaling Activity with Unique Clinical Phenotype in JAK2-Mutated Myeloproliferative Neoplasms.” Haematologica, vol. 102, no. 3, Jan. 2017, pp. 509–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....105b72e2a3ead2882f77cf97e9bf0681&authtype=sso&custid=ns315887.

APA

Yu-Wei Leu, Kuan Der Lee, Chang Hsien Lu, Yi Yang Chen, Chih-Cheng Chen, Jie Yu You, Chia-Chen Hsu, Chian Pei Li, Jyh Pyng Gau, Hsing-Ying Ho, Cih-En Huang, & Jrhau Lung. (2017). Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms. Haematologica, 102(3), 509–518.

Chicago

Yu-Wei Leu, Kuan Der Lee, Chang Hsien Lu, Yi Yang Chen, Chih-Cheng Chen, Jie Yu You, Chia-Chen Hsu, et al. 2017. “Aberrant Let7a/HMGA2 Signaling Activity with Unique Clinical Phenotype in JAK2-Mutated Myeloproliferative Neoplasms.” Haematologica 102 (3): 509–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....105b72e2a3ead2882f77cf97e9bf0681&authtype=sso&custid=ns315887.